|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boffetta P and Nyberg F: Contribution of
environmental factors to cancer risk. Br Med Bull. 68:71–94. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Didkowska J, Manczuk M, McNeill A, Powles
J and Zatonski W: Lung cancer mortality at ages 35–54 in the
European Union: Ecological study of evolving tobacco epidemics.
BMJ. 331:189–191. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ridge CA, McErlean AM and Ginsberg MS:
Epidemiology of lung cancer. Semin Intervent Radiol. 30:93–98.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Debevec L and Debeljak A:
Multidisciplinary management of lung cancer. J Thorac Oncol.
2:5772007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jian H, Zhao Y, Liu B and Lu S: SEMA4b
inhibits MMP9 to prevent metastasis of non-small cell lung cancer.
Tumour Biol. 35:11051–11056. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang R, Chen X, Xu T, Xia R, Han L, Chen
W, De W and Shu Y: MiR-326 regulates cell proliferation and
migration in lung cancer by targeting phox2a and is regulated by
HOTAIR. Am J Cancer Res. 6:173–186. 2016.PubMed/NCBI
|
|
8
|
Lu S, Azada MC and Ou SH: Choroidal
metastasis response to crizotinib in a ROS1-rearranged NSCLC
patient. Lung Cancer. 87:207–209. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwak PB, Iwasaki S and Tomari Y: The
microRNA pathway and cancer. Cancer Sci. 101:2309–2315. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Zeng C, Tu M, Jiang W, Dai Z, Hu Y,
Deng Z and Xiao W: MicroRNA-200b acts as a tumor suppressor in
osteosarcoma via targeting ZEB1. Onco Targets Ther. 9:3101–3111.
2016.PubMed/NCBI
|
|
13
|
Zhao JJ, Chen PJ, Duan RQ, Li KJ, Wang YZ
and Li Y: miR-630 functions as a tumor oncogene in renal cell
carcinoma. Arch Med Sci. 12:473–478. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lei T, Zhu Y, Jiang C, Wang Y, Fu J, Fan Z
and Qin H: MicroRNA-320 was downregulated in non-small cell lung
cancer and inhibited cell proliferation, migration and invasion by
targeting fatty acid synthase. Mol Med Rep. 14:1255–1262.
2016.PubMed/NCBI
|
|
15
|
Zhang P, Zuo Z, Wu A, Shang W, Bi R, Jin
Q, Wu J and Jiang L: miR-600 inhibits cell proliferation, migration
and invasion by targeting p53 in mutant p53-expressing human
colorectal cancer cell lines. Oncol Lett. 13:1789–1796.
2017.PubMed/NCBI
|
|
16
|
Yu H, Duan P, Zhu H and Rao D: miR-613
inhibits bladder cancer proliferation and migration through
targeting SphK1. Am J Transl Res. 9:1213–1221. 2017.PubMed/NCBI
|
|
17
|
Zhao Y, Yan M, Yun Y, Zhang J, Zhang R, Li
Y, Wu X, Liu Q, Miao W and Jiang H: MicroRNA-455-3p functions as a
tumor suppressor by targeting eIF4E in prostate cancer. Oncol Rep.
37:2449–2458. 2017.PubMed/NCBI
|
|
18
|
Zhao X, Zhou Y, Chen YU and Yu F: miR-494
inhibits ovarian cancer cell proliferation and promotes apoptosis
by targeting FGFR2. Oncol Lett. 11:4245–4251. 2016.PubMed/NCBI
|
|
19
|
Chen H, Luo Q and Li H: MicroRNA-590-3p
promotes cell proliferation and invasion by targeting inositol
polyphosphate 4-phosphatase type II in human prostate cancer cells.
Tumour Biol. 39:10104283176959412017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang C, Zhang X, Wang HM, Liu XM, Zhang
XJ, Zheng B, Qian GR and Ma ZL: MicroRNA-18a-5p functions as an
oncogene by directly targeting IRF2 in lung cancer. Cell Death Dis.
8:e27642017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin N, Zhou Y, Lian X and Tu Y:
MicroRNA-31 functions as an oncogenic microRNA in cutaneous
squamous cell carcinoma cells by targeting RhoTBT1. Oncol Lett.
13:1078–1082. 2017.PubMed/NCBI
|
|
22
|
Duan J, Zhang H, Qu Y, Deng T, Huang D,
Liu R, Zhang L, Bai M, Zhou L, Ying G and Ba Y: Onco-miR-130
promotes cell proliferation and migration by targeting TGFβR2 in
gastric cancer. Oncotarget. 7:44522–44533. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The microRNA.org resource: Targets and expression.
Nucleic Acids Res. 36:(Database issue). D149–D153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wong N and Wang X: miRDB: An online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43:(Database issue). D146–D152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X: Improving microRNA target
prediction by modeling with unambiguously identified
microRNA-target pairs from CLIP-ligation studies. Bioinformatics.
32:1316–1322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar
|
|
28
|
Huang N, Lin J, Ruan J, Su N, Qing R, Liu
F, He B, Lv C, Zheng D and Luo R: MiR-219-5p inhibits
hepatocellular carcinoma cell proliferation by targeting
glypican-3. FEBS Lett. 586:884–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang C, Cai Z, Huang M, Mao C, Zhang Q,
Lin Y, Zhang X, Tang B, Chen Y and Wang XE: miR-219-5p modulates
cell growth of papillary thyroid carcinoma by targeting estrogen
receptor α. J Clin Endocrinol Metab. 100:E204–E213. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiong GB, Zhang GN, Xiao Y, Niu BZ, Qiu
HZ, Wu B, Lin GL, You L and Shu H: MicroRNA-219-5p functions as a
tumor suppressor partially by targeting platelet-derived growth
factor receptor alpha in colorectal cancer. Neoplasma. 62:855–863.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi JA, Lu DL, Huang X and Tan W: miR-219
inhibits the proliferation, migration and invasion of
medulloblastoma cells by targeting CD164. Int J Mol Med.
34:237–243. 2014.PubMed/NCBI
|
|
32
|
Song KB, Liu WJ and Jia SS: miR-219
inhibits the growth and metastasis of TSCC cells by targeting
PRKCI. Int J Clin Exp Med. 7:2957–2965. 2014.PubMed/NCBI
|
|
33
|
Cheng J, Deng R, Zhang P, Wu C, Wu K, Shi
L, Liu X, Bai J, Deng M, Shuai X, et al: miR-219-5p plays a tumor
suppressive role in colon cancer by targeting oncogene Sall4. Oncol
Rep. 34:1923–1932. 2015.PubMed/NCBI
|
|
34
|
Rao SA, Arimappamagan A, Pandey P, Santosh
V, Hegde AS, Chandramouli BA and Somasundaram K: miR-219-5p
inhibits receptor tyrosine kinase pathway by targeting EGFR in
glioblastoma. PLoS One. 8:e631642013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiang Y, Yin L, Jing H and Zhang H:
MicroRNA-219-5p exerts tumor suppressor function by targeting ROBO1
in glioblastoma. Tumour Biol. 36:8943–8951. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reeves R and Nissen MS: The
A.T-DNA-binding domain of mammalian high mobility group I
chromosomal proteins. A novel peptide motif for recognizing DNA
structure. J Biol Chem. 265:8573–8582. 1990.PubMed/NCBI
|
|
37
|
Wu Y, Song Y and Liu H: Expression and its
clinical significance of HMGA2 in the patients with non-small cell
lung cancer. Zhongguo Fei Ai Za Zhi. 11:377–381. 2008.(In Chinese).
PubMed/NCBI
|
|
38
|
Meyer B, Loeschke S, Schultze A, Weigel T,
Sandkamp M, Goldmann T, Vollmer E and Bullerdiek J: HMGA2
overexpression in non-small cell lung cancer. Mol Carcinog.
46:503–511. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kumar MS, Armenteros-Monterroso E, East P,
Chakravorty P, Matthews N, Winslow MM and Downward J: HMGA2
functions as a competing endogenous RNA to promote lung cancer
progression. Nature. 505:212–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
